Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 201.29

+0.2%

Nov 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (28937)	6/23/1999 11:05:00 PM
From: WTDEC	Read Replies (4) of 32384

Henry, when you get a chance could you please explain what the two percentages after [C.I.] in the following quote means? "At the initial dose level of 300 mg/m2/day proposed for marketing, Targretin capsules produced at least 50% improvement (partial response or clinical complete response) in 48% (40/84, 95% confidence intervals [C.I.] 37% to 58%) of patients" Also, it appears to me that approval of Targretin won't quite be the 'slam-dunk' that Panretin gel was. Your thoughts on the chances for approval would be appreciated. Best regards, Walter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next